Affimed NV (NASDAQ:AFMD) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.21) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.24) by $0.03. Affimed NV had a negative net margin of 501.31% and a negative return on equity of 57.35%. The firm had revenue of $1.94 million during the quarter, […]
